Abstract
Pathogenic brain aging and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are characterized by chronic neuroinflammation and the accumulation of dysfunctional or misfolded proteins that lead to progressive neuronal cell death. Here we demonstrate that a murine model with global loss of the CUL4-DDB1 substrate receptor WDR23 (Wdr23KO) results in changes in multiple age-related hippocampal-dependent behaviors. The behavioral differences observed in Wdr23KO animals accompany the stabilization of the NRF2/NFE2L2 protein, an increase in RNA transcripts regulated by this cytoprotective transcription factor, and an increase in the steady state level of antioxidant defense proteins. Taken together, these findings reveal a role for WDR23-proteostasis in mediating cytoprotective capacity in the hippocampus and reveal the potential for targeting WDR23-NRF2 signaling interactions for development of therapies for neurodegenerative disorders.
Keywords: Wdr23, NRF2/NFE2l2, hippocampus, behavior, mouse
INTRODUCTION
The NFE2L2/NRF2 transcription factor functions as a regulator of oxidative stress and neuroinflammation in addition to many other metabolic responses [1–3]. Although a large body of evidence documents the proteostatic regulation of NRF2 by CUL3-KEAP1, regulation by the CUL4-DDB1-WDR23 E3-ubiquitin ligase also plays important roles [4, 5]. NRF2 is an important homeostat that manages oxidative stress resistance pathways that are critical for health across tissues and throughout the lifespan.
Oxidative stress, a result of the imbalance between free radicals and antioxidants, is recognized as a fundamental contributor to the aging process [6]. The brain exhibits a pronounced requirement for ATP originating from mitochondrial metabolism, resulting in constant generation of free radicals and reactive oxygen species (ROS) [7]. Neurons, in particular, exhibit a heightened susceptibility to oxidative stress-induced damage over the lifespan and as a result, complex mechanisms are employed to alleviate the effect of oxidative-stress [8]. Accumulating evidence has shown that excessive oxidative stress can lead to the gradual deterioration of brain tissues, which contributes to age-related cognitive decline and an increased vulnerability to many disorders [9, 10].
In this context, NRF2 emerges as a central player in the aging narrative. NRF2 acts as a transcription factor that regulates the expression of antioxidant and detoxification genes, thereby helping to mitigate oxidative stress and inflammation [1, 11–13]. Beyond its role in oxidative stress resistance, NRF2 has been increasingly recognized for its involvement in age-related diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) [14–16]. Thus, understanding the mechanisms through which NRF2 and other oxidative stress resistance pathways modulate brain aging, is paramount in advancing our knowledge of neurodegenerative disorders and promoting healthy aging.
An emerging body of evidence has shed light on the discrepancies in redox signaling between the sexes [17, 18]. These sex-related differences in coping with oxidative stress extend beyond normal physiological context, and confer distinct advantages to females, including a longer lifespan and reduced susceptibility to many diseases characterized by oxidative stress [17, 19, 20]. However, it is worth highlighting an augmented vulnerability to AD among females [21, 22]. Research indicates that a number of factors, including sex hormones [23–25], sex chromosome genes [26, 27], mitochondrial functions [28, 29] and their interplays can impact brain function and cognitive aging differently compared to males. Nevertheless, the precise mechanistic underpinnings as to why females are protected from certain oxidative stress-related diseases but vulnerable toothers, remains an unexplored area of research.
In this study, we examine the impact of genetic disruption of Wdr23 on age-related changes in behavior in the murine model, and document changes in the NRF2 homeostat in the hippocampus. Collectively, this work reveals a conserved role for WDR23-dependent proteostatic control of NRF2 in the nervous system, which provides a new model for manipulating NRF2 activity in the aging brain that can complement models disrupting KEAP1 regulation and result pleiotropic outcomes.
MATERIALS AND METHODS
Animals
All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Southern California and all the procedures were conducted in compliance with institutional guidelines and protocols.
Wdr23 knock-out (Wdr23KO) mice were generated by Wellcome Trust Sanger Institute [30, 31]. Wdr23KO animals were subsequently backcrossed nine times into our C57BL/6J (WT) strain from the Jackson laboratory [4, 5]. Heterozygous (Wdr23 +/−) dams and sires were then mated to generate Wdr23+/+ and Wdr23−/− animals that were maintained as WT and KO, respectively. Mice were kept in a 12:12 h light-dark cycle, constant temperature, and humidity room. All animals were allowed ad libitum access to water and food.
Rodent diets
Mice were fed ad lib with irradiated D12450K rodent chow (Research Diets), containing 16.1kJ/g of digestible energy (animal-based protein 3.22kJ/g, carbohydrate 11.27kJ/g, fat 1.61 kJ/g).
RNA extraction and RNA sequencing
The hippocampus tissue of 44 weeks old male mice was collected and lysed in RNeasy Lipid Tissue mini kit reagent (QIAGEN). RNA was extracted according to the manufacturer’s protocol. Qubit RNA BR Assay Kit was used to determine RNA concentration. Isolated RNA was sent to Novogene for library preparation and deep sequencing in biological replicates (N=6 WT, N=4 Wdr23KO). The read counts were then used for differential expression (DE) analysis by using the R package DEseq2 (R version 3.5.2). Differentiated expressed genes were analyzed using p value <0.05 and fold change >1.5 as cutoff.
Western blot analysis
The hippocampus tissue of 8–14 weeks old male mice was collected for WB analysis. Whole cell lysates were prepared in M-PER buffer (1x Mammalian Protein Extraction Reagent (Thermo Scientific), 0.1% Halt Protease & Phosphatase inhibitor (Thermo Scientific) according to the manufacturer’s protocol. Total protein concentrations were quantified by Bradford assay (Sigma). An equal amount of protein (20 μg) was separated on 4%−12% bis-tris polyacrylamide gel (Invitrogen,) in MOPS running buffer (Invitrogen) and then transferred to nitrocellulose membranes (GE Healthcare Life science). After blocking for 1 h with 3% BSA in PBST (PBS, 0.1% Tween 20), the membranes were subjected to immunoblot analysis. Antibodies used include: NFE2L2/NRF2 (Proteintech, 1:1000), ALDH2 (Proteintech, 1:1000) GCLM (Proteintech, 1:1000), NQO1 (Proteintech, 1:1000), GPx4 (Proteintech, 1:1000), GPx1 (Proteintech, 1:1000)), GSTA4 (Proteintech, 1:500), SOD1 (Proteintech, 1:1000), SOD2 (Cell signaling, 1:1000), G6PD (Proteintech, 1:1000), β-actin (Millipore Sigma, 1:10000) and HRP-conjugated secondary antibodies (Thermo Fisher, 1:10,000). Specific protein bands were visualized and evaluated using FluorChem HD2 (ProteinSimple).
Behavioral Assays
Prior to behavioral tests, mice were habituated to the testing room for 30 minutes. Arenas and objects were thoroughly cleaned between mice using 70% (vol/vol) ethanol. Test trials were video recorded and analyzed using Noldus Ethovision XT software (Version 16).
Spontaneous Alteration Tests (SAB).
The arena consisted of three arms (x cm) spaced at 120-degree angles. Mice were placed in one of the arms and allowed to explore freely for 5 minutes. An arm entry was considered when the animal placed all four paws into the arm. Three consecutive entries into different arms were considered an alteration. The total number of arm entries was recorded, and the percentage of correct alterations was calculated.
Open Field Tests.
The open field tests were conducted the day after SAB. Mice were gently placed in the center of a square arena (40 × 40 cm) and allowed to explore freely for a duration of 10 minutes. The arena was divided into 16 equal squares, with the center area defined by the middle 4 squares. Throughout the trial, total distance moved, the overall time the mice remained mobile, and the time spent in the center area were recorded. To calculate the average velocity, the total distance moved was divided by the total time of mobility.
Novel object placement and recognition.
We employed a four-day protocol to evaluate the recognition memory. Same arena in the open field test was used. Open field test was considered as day 1 habituation of novel object placement and recognition tests. On day 2, each animal was given another habituation trial performed as day 1. On day 3 (familiarization and novel object placement), the test arena was prepared with two identical objects positioned in adjacent corners. The mice were placed in the arena, facing opposite to the objects, and allowed to explore for 10 minutes. After 1 hour, the animals were reintroduced to the arena, but with one of the identical objects moved to the diagonally opposite corner. The mice were again allowed to explore for 10 minutes. On day 4 (novel object recognition), 24 hours after the familiarization trial, mice were placed in the arena and allowed to explore for 10 minutes with one of the familiar objects replaced with a novel object. Throughout all trials, exploration time for each object was recorded. Percentage of time exploring each object was calculated.
Physiological cages
Metabolic assessments were conducted using the PhenoMaster system (TSE-Systems) as previously described [32]. One week after the last behavioral test, mice were individually housed in PhenoMaster cages and subjected to automated monitoring over a span of four days. The initial day was designated as an acclimation period, and data were computed as the mean values obtained from days 2 to 4. Ambulatory activity was calculated as total counts of breaking beams in the x, y, and z axes. Respiratory exchange ratio (RER) was calculated as the ratio between production of carbon dioxide and consumed volume of oxygen. Energy expenditure in each animal was normalized by their whole-body weight.
Primary cell culture
Primary cortical neurons or mixed glia were isolated from embryonic day 17 (E17) fetuses from timed-pregnant C57BL/6J WT or Wdr23KO age-matched mice. Briefly, brains were removed in cold Hanks Balanced Salt Solution HBSS containing 10 mM HEPES, cerebral cortices including hippocampus were dissected from 5–8 brains, meninges removed, and incubated for 10 min at 37°C in trypsin containing HBSS. Cells were dissociated with pipet then poured through a 40-micron filter. Cells were counted by hemacytometer then seeded at a density of 1 million cells per well in 6-well poly-D-lysine pre-coated plates (Greiner Bio-One) and incubated at 37°C, 5% CO2. Neurons were cultured for 7–10 days in complete Neurobasal Plus Medium (Gibco). Mixed glial cells were cultured with the same cortical cell isolation procedure, first seeded in T75 flasks (Corning) and grown for approximately 2 weeks to reach 80–90% confluency in Dulbecco’s Modified Eagle Medium (DMEM; Gibco) with 10% fetal bovine serum and 1% antibiotic-antimycotic (Corning). Mixed glial cultures adhered to T75 flask were then trypsinized and re-plated in 6-well plates at a density of 1 million cells per well and observed to be 80–90% confluent. Cells were harvested 24 hours after fresh media changes. Cells were rinsed in warm Dulbecco’s Phosphate Buffered Saline (DPBS) to remove media and debris then lysed with M-PER Mammalian Protein Extract Reagent (Thermo) containing Halt protease inhibitors (Thermo). Total cell lysates were collected on ice followed by centrifugation (10,000 × g for 10 min at 4°C) to extract soluble proteins for immunoblots.
Statistical Analysis
All experiments were performed at least in triplicate. Data are presented as mean ± SEM. Data handling and statistical processing were performed using GraphPad Prism 8.0. In SAB and open field test, data were analyzed using two-way ANOVAs with genotype and age as between-subjects factors. For novel object placement and recognition, percentage of time exploring moved or novel object in each group was compared with 50% using one-sample t-test or Wilcoxson signed-rank test. Measurements from physiological cages were analyzed using either repeated two-way ANOVAs across time points and genotype as a between-subjects factors, or two-way ANOVAs with genotype and age as between-subjects factors. For all ANOVAs, Greenhouse-Geisser correction was performed and followed by Tukey’s post hoc tests. All other comparisons between two groups were done using unpaired Student’s t-test. The Kolmogorov-Smirnov test and/or Shapiro-Wilk test was conducted on all datasets to assess normality. Differences were considered significant at the p < 0.05 level. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, compared to C57BL/6J (WT) control or indicated with brackets. Statistical analyses are listed in Supplemental Table S1.
RESULTS AND DISCUSSION
Wdr23KO animals display age-related differences in behavior
A decline of neuronal proteostasis during natural aging or extreme stress can lead to neuronal disorders [33]. To investigate the impact of the proteostasis regulator Wdr23 on aging-related changes in behavior, we conducted a series of cognitive assessments in a mouse model lacking Wdr23 (Wdr23KO) and compared them with wild-type (WT) controls at different ages (young, 4-month-old; middle/late-aged, 16-month-old).
Firstly, we employed the novel object recognition (NOR) and placement (NOP) tasks (Figure 1A) to gauge cognitive function in these animals (Figure 1 and Figure S1). The NOR task assesses the ability to distinguish object identity, a cognitive function reliant on various brain regions [34]. In our observations, WT male mice exhibited memory for the novel object only at 16 months, a trait was not observed in Wdr23KO males across both age groups (Figure 1B). Meanwhile, WT female mice maintained their recognition of the novel object at 16 months. In contrast, young Wdr23KO females showed difficulty in differentiating the novel object but improved in middle-aged Wdr23KO females (Figure 1C). In the NOP task, which evaluates spatial recognition and the capacity to detect changes in the arrangement of objects [35], young Wdr23KO of both sexes initially displayed limited discrimination ability regarding the newly positioned object in the NOP task. However, it is noteworthy that this capacity became more pronounced in older Wdr23KO. In contrast, WT animals showed an age-related decline of performance in this task, as only young WT animals can discriminate the newly positioned object (Figure 1D–E). These findings indicate that the impact of Wdr23 deficiency on cognitive function varies depending on the specific cognitive domain assessed, emphasizing the complexity of cognitive processes and their modulation by Wdr23 during aging.
Figure 1. Wdr23 effects on recognition memory.

(A) Schematic representation of the experimental novel object placement (NOP) and recognition tests (NOR) experimental designs. Percentage of time exploring the novel object in (B-C) NOR and moved object in (D-E) NOP tests in (B,D) male and (C,E) female mice. Data are presented as mean (+SEM) values. n=7–17/group. * denotes p < 0.05, ** denotes p < 0.01.
We next assessed spontaneous alternating behavior (SAB) as a measure of exploratory behavior and spatial working memory (Figure 2A). Our analysis of the SAB task revealed no statistically significant differences between male WT and Wdr23KO animals concerning the percentage of correct alterations in the SAB task (Figure 2B). However, in the case of female mice, the absence of Wdr23 was associated with improved SAB performance (Figure 2C). suggesting enhanced spatial working memory. Notably, young Wdr23KO males exhibited elevated levels of activity in such tests, as evidenced by an increased number of arm entries (Figure S2A). Conversely, young WT females displayed a significant decline in arm entries with age, a trend that was not observed in Wdr23KO animals (Figure S2B). It remains possible that these trends, while not statistically significant at this stage, may potentially become significant at a more advanced age. These findings emphasize the gender-specific and age-related variations in exploratory behavior and spatial working memory in response to Wdr23 deficiency. Our results are consistent with previous findings suggesting a role of NRF2 in cognitive function. Loss of NRF2 leads to faster cognitive decline in older mice [36]. Activating NRF2 in middle-aged mice boosts memory by enhancing mitochondrial and antioxidant functions in the brain [37]. NRF2 also affects neural stem cells (NSPCs) function during aging. Transplanting NRF2-overexpressing NSPCs into the brain improves cognitive abilities in middle age [38], and overexpressing NRF2 in aged NSPCs increases their survival and regeneration [39]. While NRF2 overexpression benefits cognition in older age, its early-age impact is uncertain. Imbalances in NRF2 expression may affect cognitive processes, highlighting the need for further research on NRF2’s role at various life stages. Our study presents a new model of NRF2 activation, through loss of the negative regulator WDR23 [4, 5] that could be leveraged pharmacological target.
Figure 2. Wdr23 effects on short-term working memory.

(A) Illustrative cartoons showing examples of a correct and an incorrect spontaneous alternation behavior (SAB). Percentage of correct alternations were calculated in (B) male and (C) female mice. Dashed lines represent the 50% alteration level. Data are presented as mean (+SEM) values. n=7–17/group. Statistically significant main effect is denoted G (genotype).
Lastly, to gain insights into general explorative activity levels, gross locomotor activity, and exploration habits, we conducted the open field task (Figure 3A). In both older males (Figure 3A–B) and females (Figure 3C–D), Wdr23KO animals displayed notable differences in behavior. One key metric we examined was the amount of time spent in the center of the field, which is often indicative of anxiety levels in rodents [40]. Interestingly, Wdr23KO animals, in both sexes, spent more time in the center, suggesting a reduced state of anxiety compared to their WT counterparts. Furthermore, we assessed overall exploratory activity by measuring the total distance moved and the total time spent in motion, providing insights into locomotor activity and the propensity to explore the novel environment (Figure S3). Aged male Wdr23KO animals exhibited an overall reduction in exploratory activity when compared to their WT counterparts, as evidenced by decreased total distance moved and reduced total time spent in motion (Figure S3A–B). Similar to the observation in the SAB test, overall female Wdr23KO animals displayed diminished movement, a characteristic that did not show a further decline with age (Figure S3D–F). The absence of an age-related decline might suggest that Wdr23 does not play a role in these behaviors, or that the impact of WDR23 action does not manifest at middle age and that old animals (> 2 years) might be more informative. Nevertheless, the modest differences in the behavioral assessments reveal that loss of Wdr23 can influence animal behaviors with age, relative to age-matched WT controls.
Figure 3. Wdr23 effects on exploration behavior and anxiety.

The heatmaps of the activity of (A) male and (C) female mice in the open field test. Percentage of time spent in the center in (B) male and (D) female mice. Data are presented as mean (+SEM) values. n=7–17/group. Statistically significant main effects are denoted by G (genotype) and I (age and genotype interaction). ** denotes p < 0.01.
Wdr23KO animals have altered home-cage activity and respiratory exchange ratio
Recent findings suggest that Nrf2 plays a role in regulating energy metabolism [41, 42]. Therefore, we accessed home-cage physical activity, respiratory exchange ratio (RER), and energy expenditure using physiological cages in Wdr23KO and WT animals of both sexes. In young male mice, it was evident that WT animals exhibited higher levels of spontaneous activity when compared to Wdr23KO mice (Figure 4A). However, as mice aged, we noticed an age-related increase in activity exclusively in Wdr23KO animals (Figure 4C–D). Conversely, in the case of female mice, we found that WT animals demonstrated higher activity levels than Wdr23KO mice, although this difference was only notable in the older groups (Figure 4J). Interestingly, the aging process was linked to a decrease in activity, but this reduction was specifically observed in Wdr23KO female mice (Figure 4K–L). These findings highlight the potential role of Wdr23 in modulating physical activity levels, which, in the context of energy metabolism, can have implications for overall metabolic health and the aging process.
Figure 4. Wdr23 effects on respiration exchange ratio and activity.

Total activity and respiratory exchange ratio (RER) were measured in physiological cages. Averaged activity at different time points during the last three days in (A) 4-month-old male, (B) 16-month-old male mice. Total activity in different ages of male mice during (C) daytime and (D) nighttime. Averaged RER in (E) 4-month-old male, (F) 16-month-old male mice. Averaged RER in different ages of male mice during (G) daytime and (H) nighttime. (I-K) Averaged activity and (M-P) RER were also measured in (I,M) 4-month-old female and (J-N) 16-month-old female mice. Data are presented as mean (+SEM) values. n=4–5/group. * denotes p < 0.05, ** denotes p < 0.01, ** denotes p < 0.0001.
During the daytime, but not during nighttime, young male Wdr23KO animals exhibited significant lower RER when compared to aged-matched WT counterparts. The higher RER measured in WT animals suggests an increased utilization of carbohydrates as compared to Wdr23KO mice during the daytime (Figure 4E, G). We also observed an age-related decline of RER in male WT animals during both daytime and nighttime, but this difference was only evident during nighttime in Wdr23KO animals. It is important to note that by the 16-month mark, both WT and Wdr23KO animals reached similar RER values, despite the initial differences(Figure 4H). Likewise, young female Wdr23KO animals also displayed reduced RER levels compared with WT mice (Figure 4M). Notably, a decline in RER with age during nighttime was observed only in female WT animals, a trend absents in female Wdr23KO mice (Figure 4P). Despite these differences in trends, both female WT and Wdr23KO animals ultimately converged to similar RER values at 16 months (Figure 4P). The absence of Wdr23 had a notable impact on the change in energy expenditure with age in male mice. Specifically, middle-aged male Wdr23KO animals, but not WT animals, exhibited lower energy expenditure than their younger counterparts (Figure S4A–B). However, in female mice, neither age nor the presence or absence of Wdr23 seemed to significantly affect energy expenditure (Figure S4C–D). Our observations align with previous findings suggesting sexual dimorphism in energy metabolism during aging processes, with females showing a more favorable metabolic profile in advanced age. For example, aged male rats were characterized by hyperglycemia and impaired glucose tolerance relative to both young male and aged female cohorts [43]. This sex difference is of great interest and future studies uncovering why males and females exhibit a dimorphic response to the loss of Wdr23 could add to our understanding of sexual dimorphism in the brain and in healthy aging in general.
Wdr23KO animals activate hippocampal NFE2L1/NFE2L2
The brain is under the constant need to maintain homeostasis (e.g., energetic [44], proteostatic [33], redox [8]) that is mediated in part at the level of transcriptional homeostasis. To discern whether the loss of Wdr23 resulted in a specific molecular response in the hippocampus, we performed RNAseq on dissected hippocampi from Wdr23KO mice and compared to samples from age-matched WT animals. 46 genes displayed a significant difference in expression (Figure 5A, Table 1) of which over 40% (20/46) have NFE2L1/NFE2L2 binding sites in the promoter region of the gene (Figure 5B).
Figure 5. Genetic loss of Wdr23 increases hippocampal NFE2L2/NRF2 activity.

(A) Volcano plot of differentially expressed genes between 44 weeks old WT and Wdr23KO male mice. Each gene is represented as single dot. The mean expression level for each gene is indicated by log2FoldChange. Genes that reached the significance threshold (adjusted p-value < 0.05) are shown as red dots. (B) Of the 46 gene transcripts with a significant difference in expression, 20 of these genes contain NFE2L1/NFE2L2 binding elements [53]. (C, D) Western blot analysis of NFE2L2/NRF2 protein revealed increased steady-state levels in young (8–14 week) Wdr23KO male mice hippocampus. ****p<.0001, compared to age matched WT (C57BL/6J) control; n=6/group.
Table 1.
| log2Fold Change |
padj | Gene name | Description | ||
|---|---|---|---|---|---|
| −1.707 | 0.035 | 6530403H02Rik | lncRNA gene | ||
| −1.366 | 6.53E-48 | Dcaf11 | X | X | DDB1 and CUL4 associated factor 11 |
| −0.836 | 0.038 | Nkd2 | naked cuticle 2 | ||
| −0.455 | 0.038 | Dgkb | diacylglycerol kinase, beta | ||
| −0.444 | 0.038 | Tomm34 | X | X | translocase of outer mitochondrial membrane 34 |
| −0.287 | 0.037 | Cpe | carboxypeptidase E | ||
| 0.517 | 0.038 | Selenon | selenoprotein N | ||
| 0.564 | 0.040 | Relt | X | RELT tumor necrosis factor receptor | |
| 0.599 | 0.006 | H2-D1 | X | histocompatibility 2, D region locus 1 | |
| 0.607 | 0.038 | Ier5l | X | immediate early response 5-like | |
| 0.678 | 0.005 | Necab3 | X | X | N-terminal EF-hand calcium binding protein 3 |
| 0.736 | 0.034 | Epb41 | erythrocyte membrane protein band 4.1 | ||
| 0.745 | 0.043 | Myoc | X | myocilin | |
| 0.745 | 0.043 | Rgs16 | X | X | regulator of G-protein signaling 16 |
| 0.763 | 0.043 | Klhl33 | kelch-like 33 | ||
| 0.772 | 0.043 | Hr | lysine demethylase and nuclear corepressor | ||
| 0.775 | 0.043 | Gm42756 | lncRNA gene | ||
| 0.839 | 0.044 | Gpr3 | X | G-protein coupled receptor 3 | |
| 0.861 | 0.045 | Coro6 | X | coronin 6 | |
| 0.879 | 0.031 | H2-T23 | histocompatibility 2, T region locus 23 | ||
| 0.954 | 0.034 | Kcnab3 | X | potassium voltage-gated channel, shaker-related | |
| 0.981 | 0.034 | Plcb4 | phospholipase C, beta 4 | ||
| 1.052 | 0.002 | Lrrc55 | leucine rich repeat containing 55 | ||
| 1.054 | 0.010 | Adcyap1 | X | adenylate cyclase activating polypeptide 1 | |
| 1.061 | 0.041 | Syt9 | synaptotagmin IX | ||
| 1.161 | 0.040 | Ptgds | X | prostaglandin D2 synthase (brain) | |
| 1.175 | 0.016 | Thbs2 | thrombospondin 2 | ||
| 1.186 | 1.68E-04 | Cpne9 | X | copine family member IX | |
| 1.257 | 6.85E-05 | Ogn | osteoglycin | ||
| 1.423 | 1.12E-04 | Syt6 | synaptotagmin VI | ||
| 1.455 | 0.005 | Aldh1a2 | X | X | aldehyde dehydrogenase family 1, subfamily A2 |
| 1.477 | 0.020 | Sema3f | secreted, (semaphorin) 3F | ||
| 1.501 | 0.007 | Synpo2 | synaptopodin 2 | ||
| 1.518 | 0.010 | Fmod | fibromodulin | ||
| 1.539 | 0.002 | Sncg | X | X | synuclein, gamma |
| 1.542 | 0.038 | Ret | ret proto-oncogene | ||
| 1.747 | 0.011 | Rnf17 | ring finger protein 17 | ||
| 1.880 | 0.040 | Chrna3 | cholinergic receptor, nicotinic, alpha 3 | ||
| 1.938 | 0.010 | Fst | X | X | follistatin |
| 1.966 | 0.034 | Gpr139 | G protein-coupled receptor 139 | ||
| 2.040 | 0.022 | Chrnb3 | cholinergic receptor, nicotinic, beta polypeptide 3 | ||
| 2.051 | 0.010 | Irx1 | X | Iroquois homeobox 1 | |
| 2.448 | 0.005 | Krt80 | X | keratin 80 | |
| 3.734 | 0.043 | Gng14 | G protein subunit gamma 14 (Gm5741) | ||
| 5.510 | 0.015 | Gstp2 | X | X | glutathione S-transferase, pi 2 |
| 5.791 | 0.034 | Rln3 | relaxin 3 |
NFE2L1 and NFE2L2 regulation was identified as previously described [53].
The activity of NRF2/NFE2L2 is regulated by the post-translational degradation of the protein during normal unstressed conditions [45]. We isolated total protein from dissected hippocampus (Figure 5C–D) and detected NRF2/NFE2L2 by Western blot analysis. We measured a >150% increase in total NRF2/NFE2L2 protein in Wdr23KO (Figure 5D), suggesting a steady state stabilization in the absence of stress when WDR23-dependent proteostasis is perturbed [5]. We next isolated and cultured cortical neurons (Figure S5A–B) and mixed glia (Figure S5C–D) from WT and Wdr23KO mice, which displayed a similar increased stabilization of NRF2/NFE2L2. Taken together, these data confirm the role of WDR23 for the proteostatic control of total NRF2/NFE2L2 in the murine brain, which supports the action for the CUL4-DDB1-WDR23 system working in parallel with CUL3-KEAP1 [46] in the brain as it does in the periphery [4, 5]. Although recent work has demonstrated that female sex hormones do not significantly contribute to sexually dimorphic behavioral responses [47], there is evidence that estrogen can rapidly activate NRF2/NFE2L2 [48]. Furthermore, another study highlighted sex-specific variations in skeletal muscle expression of NRF2 and its target proteins. Specifically, it was observed that mice treated with rapamycin, a known activator of the NRF2 pathway, levels of NQO1, NRF2, and SOD-1 protiens were significantly higher in skeletal muscle of male mice in comparision to females [49]. This suggested possible sex differences in the NRF2 cytoprotective pathway. Therefore, our study focused on examining biochemical and molecular changes in NRF2 activity exclusively in male Wdr23KO animals.
Enhanced capacity for stress resistance in hippocampus of Wdr23KO mice
To test whether the increase in established NFE2L2/NRF2-regulated transcripts measured in Wdr23KO hippocampus resulted in an increase in steady state abundance of stress adaptation proteins, we quantified the steady state level of several proteins with roles in redox and oxidative stress resistance [54]. We noted an increase in the abundance of several proteins that mediate survival and protection from oxidative stress [55] in the Wdr23KO relative to WT; these include the glutathione peroxidase 4 (GPX4, Figure 6A–B), glutathione S transferase 4 (GSTA4, Figure 6A,C), aldehyde dehydrogenase 2 (ALDH2, Figure 6A,D), and the manganese superoxide dismutase 2 [56] (SOD2, Figure 6E–F). Intriguingly, we could not detect an increase in all proteins with known sensitivity to NFE2L2/NRF2 activation (Figure S6). Additionally, when examining the same set of proteins in the cortical samples, we observed no significant change in NRF2 levels (Figure S5E–F) or most of other proteins involved in NRF2 signaling, contrary to our observations in the hippocampus (Figure S6). Our results suggested either a lack of sensitivity in detection for changes in the steady-state level of these proteins or possibly a unique interaction between WDR23 and NFE2L2/NRF2 regulation in the hippocampus. Future experiments could focus on comparing hippocampal NRF2 activation patterns with those in other brain regions, and employing targeted genetic or pharmacological interventions to dissect the specific role of WDR23-axis in these processes.
Figure 6. The effects of WDR23 on cellular stress resistance pathways.

Loss of Wdr23 enhanced protein expression of NRF2 target genes. Western blot analysis of GPX4 (A,B), GSTA4 (A,C), ALDH2 (A,D) and SOD2 (E,F) proteins in hippocampus of 8–14 week male mice. (G) The role of WDR23-NRF2 on cytoprotection in hippocampus. *p<.05, **p<.01, ***p<.001, ****p<.0001, compared to age matched WT (C57BL/6J) control; n=3–6/group.
In our study, we uncovered insights into the effects of the loss of Wdr23 on various behavioral and metabolic parameters. Remarkably, male and female mice often exhibited divergent responses to the loss of Wdr23, both in young and middle-aged groups. These differences not only highlight the effect of Wdr23 deficiency in the context of brain aging, but also suggest that sex plays a pivotal role in modulating the impact of Wdr23 on behavior and metabolism, and underscore the complex interplay between genetic factors, sex, and aging processes, all of which contribute to the intricate landscape of brain aging and its associated phenotypes. Further exploration of these sex-specific differences may unveil valuable insights into the development of targeted therapeutic strategies for gender- and age-specific cognitive decline and neurodegenerative diseases. Collectively, these data support a model where loss of Wdr23, stabilizes the steady-state level of NRF/NFE2L2 and results in the increased expression of targets that promote cellular stress resistance (Figure 6G), which could influence age-related changes in behavior and be an important new molecular phenotype of successful healthy brain aging.
Supplementary Material
HIGHLIGHTS.
WDR23 regulates NRF2/NFE2L2 stability in the mouse hippocampus.
Loss of Wdr23 significantly increases the expression of NFE2L2/NRF2 target genes.
Global loss of WDR23 influences age-related behaviors differentially in males and females.
ACKNOWLEDGEMENTS
We thank M. Donoghue, M. Lynn and S. Ledgerwood for technical assistance. We thank C. Ramos and Dr. N. Stuhr for critical reading of the manuscript and Dr. C. Finch for antibodies recognizing NFE2L2/NRF2 targets. This work was funded by the NIH RF1AG063947 and Hevolution Foundation HF-AGE 004 to SPC and a Glenn Foundation for Medical Research Postdoctoral Fellowship in Aging Research from the American Federation for Aging Research to CD.
ABBREVIATIONS:
- SAB
spontaneous alternating behavior
- NOP
novel object placement
- NOR
novel object recognition
- ROS
reactive oxygen species
- GST
glutathione-s-transferase
- SOD
superoxide dismutase
- NFE2L2
NFE2 like bZIP transcription factor 2
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Competing interests: All authors declare that they have no competing interests.
Data and materials availability:
All data are available in the main text.
REFERENCES:
- 1.Zgorzynska E, Dziedzic B, and Walczewska A, An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases. Int J Mol Sci, 2021. 22(17). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shaw P and Chattopadhyay A, Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms. J Cell Physiol, 2020. 235(4): p. 3119–3130. [DOI] [PubMed] [Google Scholar]
- 3.Vasileva LV, et al. , Obesity and NRF2-mediated cytoprotection: Where is the missing link? Pharmacol Res, 2020. 156: p. 104760. [DOI] [PubMed] [Google Scholar]
- 4.Spatola BN, et al. , Nuclear and cytoplasmic WDR-23 isoforms mediate differential effects on GEN-1 and SKN-1 substrates. Sci Rep, 2019. 9(1): p. 11783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lo JY, Spatola BN, and Curran SP, WDR23 regulates NRF2 independently of KEAP1. PLoS Genet, 2017. 13(4): p. e1006762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lobo V, et al. , Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev, 2010. 4(8): p. 118–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Angelova PR and Abramov AY, Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett, 2018. 592(5): p. 692–702. [DOI] [PubMed] [Google Scholar]
- 8.Cobley JN, Fiorello ML, and Bailey DM, 13 reasons why the brain is susceptible to oxidative stress. Redox Biol, 2018. 15: p. 490–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kandlur A, Satyamoorthy K, and Gangadharan G, Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance. Front Mol Neurosci, 2020. 13: p. 41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ionescu-Tucker A and Cotman CW, Emerging roles of oxidative stress in brain aging and Alzheimer’s disease. Neurobiol Aging, 2021. 107: p. 86–95. [DOI] [PubMed] [Google Scholar]
- 11.Haghani A, et al. , Air Pollution Alters Caenorhabditis elegans Development and Lifespan: Responses to Traffic-Related Nanoparticulate Matter. J Gerontol A Biol Sci Med Sci, 2019. 74(8): p. 1189–1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ma Q, Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol, 2013. 53: p. 401–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.He F, Ru X, and Wen T, NRF2, a Transcription Factor for Stress Response and Beyond. Int J Mol Sci, 2020. 21(13). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dinkova-Kostova AT, Kostov RV, and Kazantsev AG, The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J, 2018. 285(19): p. 3576–3590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Saha S, et al. , A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer’s and Parkinson’s Diseases. Front Cell Neurosci, 2021. 15: p. 787258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Suzen S, et al. , A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies. Pharmaceuticals (Basel), 2022. 15(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tower J, Pomatto LCD, and Davies KJA, Sex differences in the response to oxidative and proteolytic stress. Redox Biol, 2020. 31: p. 101488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tiberi J, et al. , Sex differences in antioxidant defence and the regulation of redox homeostasis in physiology and pathology. Mech Ageing Dev, 2023. 211: p. 111802. [DOI] [PubMed] [Google Scholar]
- 19.Kander MC, Cui Y, and Liu Z, Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med, 2017. 21(5): p. 1024–1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Allegra A, et al. , Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival. Antioxidants (Basel), 2023. 12(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tenkorang MA, Snyder B, and Cunningham RL, Sex-related differences in oxidative stress and neurodegeneration. Steroids, 2018. 133: p. 21–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sumien N, et al. , Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress. Endocrinology, 2021. 162(11). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Gurvich C, et al. , Sex Differences and the Influence of Sex Hormones on Cognition through Adulthood and the Aging Process. Brain Sci, 2018. 8(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cruz-Topete D, Dominic P, and Stokes KY, Uncovering sex-specific mechanisms of action of testosterone and redox balance. Redox Biol, 2020. 31: p. 101490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Torrens-Mas M, et al. , Sexual hormones regulate the redox status and mitochondrial function in the brain. Pathological implications. Redox Biol, 2020. 31: p. 101505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Aitken RJ and Krausz C, Oxidative stress, DNA damage and the Y chromosome. Reproduction, 2001. 122(4): p. 497–506. [DOI] [PubMed] [Google Scholar]
- 27.Xu J, Burgoyne PS, and Arnold AP, Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet, 2002. 11(12): p. 1409–19. [DOI] [PubMed] [Google Scholar]
- 28.Gaignard P, et al. , Effect of Sex Differences on Brain Mitochondrial Function and Its Suppression by Ovariectomy and in Aged Mice. Endocrinology, 2015. 156(8): p. 2893–904. [DOI] [PubMed] [Google Scholar]
- 29.Gaignard P, et al. , Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases. Front Aging Neurosci, 2017. 9: p. 406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ryder E, et al. , Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource. Mamm Genome, 2013. 24(7–8): p. 286–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.White JK, et al. , Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell, 2013. 154(2): p. 452–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Reynolds JC, et al. , MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun, 2021. 12(1): p. 470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hetz C, Adapting the proteostasis capacity to sustain brain healthspan. Cell, 2021. 184(6): p. 1545–1560. [DOI] [PubMed] [Google Scholar]
- 34.Squire LR, Wixted JT, and Clark RE, Recognition memory and the medial temporal lobe: a new perspective. Nat Rev Neurosci, 2007. 8(11): p. 872–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Vogel-Ciernia A and Wood MA, Examining object location and object recognition memory in mice. Curr Protoc Neurosci, 2014. 69: p. 8.31.1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zweig JA, et al. , Loss of NRF2 accelerates cognitive decline, exacerbates mitochondrial dysfunction, and is required for the cognitive enhancing effects of Centella asiatica during aging. Neurobiol Aging, 2021. 100: p. 48–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sadovnikova IS, et al. , Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome. Pharmaceuticals (Basel), 2021. 14(7). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ray S, et al. , A Role for Nrf2 Expression in Defining the Aging of Hippocampal Neural Stem Cells. Cell Transplant, 2018. 27(4): p. 589–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Corenblum MJ, et al. , Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle-age period. Aging Cell, 2016. 15(4): p. 725–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Seibenhener ML and Wooten MC, Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp, 2015(96): p. e52434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Meakin PJ, et al. , Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol, 2014. 34(17): p. 3305–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Schneider K, et al. , Increased Energy Expenditure, Ucp1 Expression, and Resistance to Diet-induced Obesity in Mice Lacking Nuclear Factor-Erythroid-2-related Transcription Factor-2 (Nrf2). J Biol Chem, 2016. 291(14): p. 7754–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Quirós Cognuck S, et al. , Sex differences in body composition, metabolism-related hormones, and energy homeostasis during aging in Wistar rats. Physiol Rep, 2020. 8(20): p. e14597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rosenberg AM, et al. , Brain mitochondrial diversity and network organization predict anxiety-like behavior in male mice. Nat Commun, 2023. 14(1): p. 4726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Suzuki T and Yamamoto M, Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med, 2015. 88(Pt B): p. 93–100. [DOI] [PubMed] [Google Scholar]
- 46.Tanaka N, et al. , Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. Brain research, 2011. 1370: p. 246–53. [DOI] [PubMed] [Google Scholar]
- 47.Wiseman S, Female mice behave well. Nat Neurosci, 2023. 26(4): p. 534. [DOI] [PubMed] [Google Scholar]
- 48.Ishii T and Warabi E, Mechanism of Rapid Nuclear Factor-E2-Related Factor 2 (Nrf2) Activation via Membrane-Associated Estrogen Receptors: Roles of NADPH Oxidase 1, Neutral Sphingomyelinase 2 and Epidermal Growth Factor Receptor (EGFR). Antioxidants (Basel), 2019. 8(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Bruns DR, et al. , Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models. Oxid Med Cell Longev, 2015. 2015: p. 732596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Han H, et al. , TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res, 2018. 46(D1): p. D380–D386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Zhang L, Ding Q, and Wang Z, Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner. PLoS One, 2012. 7(8): p. e42035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Liska O, et al. , TFLink: an integrated gateway to access transcription factor-target gene interactions for multiple species. Database (Oxford), 2022. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yevshin I, et al. , GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments. Nucleic Acids Res, 2017. 45(D1): p. D61–D67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Pomatto LCD and Davies KJA, Adaptive homeostasis and the free radical theory of ageing. Free Radic Biol Med, 2018. 124: p. 420–430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Tonelli C, Chio IIC, and Tuveson DA, Transcriptional Regulation by Nrf2. Antioxid Redox Signal, 2018. 29(17): p. 1727–1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Zhang Z, et al. , Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression. Mol Carcinog, 2022. 61(12): p. 1161–1176. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are available in the main text.
